Multimodal synergistic ferroptosis cancer therapy DOI
Nem Singh, Dahee Kim, Sunhong Min

et al.

Coordination Chemistry Reviews, Journal Year: 2024, Volume and Issue: 522, P. 216236 - 216236

Published: Sept. 25, 2024

Language: Английский

Chemical Design of Magnetic Nanomaterials for Imaging and Ferroptosis-Based Cancer Therapy DOI

Wei Xu,

Guoqiang Guan, Renye Yue

et al.

Chemical Reviews, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 14, 2025

Ferroptosis, an iron-dependent form of regulatory cell death, has garnered significant interest as a therapeutic target in cancer treatment due to its distinct characteristics, including lipid peroxide generation and redox imbalance. However, clinical application oncology is currently limited by issues such suboptimal efficacy potential off-target effects. The advent nanotechnology provided new way for overcoming these challenges through the development activatable magnetic nanoparticles (MNPs). These innovative MNPs are designed improve specificity ferroptosis induction. This Review delves into chemical biological principles guiding design ferroptosis-based therapies imaging-guided therapies. It discusses mechanisms attributes ferroptosis, composition MNPs, their mechanism action inducers, integration with advanced imaging techniques monitoring. Additionally, we examine convergence other strategies, chemodynamic therapy, photothermal photodynamic sonodynamic immunotherapy, within context nanomedicine strategies utilizing MNPs. highlights multifunctional surpass limitations conventional treatments, envisioning future drug-resistance-free, precision diagnostics treating recalcitrant cancers.

Language: Английский

Citations

4

Ferroptosis in Cancer Therapy: Mechanisms, Small Molecule Inducers, and Novel Approaches DOI Creative Commons

YiLin Luo,

Xin Yue Bai,

L.J. Zhang

et al.

Drug Design Development and Therapy, Journal Year: 2024, Volume and Issue: Volume 18, P. 2485 - 2529

Published: June 1, 2024

Abstract: Ferroptosis, a unique form of programmed cell death, is initiated by an excess iron accumulation and lipid peroxidation-induced damage. There growing body evidence indicating that ferroptosis plays critical role in the advancement tumors. The increased metabolic activity higher levels tumor cells make them particularly vulnerable to ferroptosis. As result, targeted induction becoming increasingly promising approach for cancer treatment. This review offers overview regulatory mechanisms ferroptosis, delves into mechanism action traditional small molecule inducers their effects on various In addition, latest progress inducing using new means such as proteolysis-targeting chimeras (PROTACs), photodynamic therapy (PDT), sonodynamic (SDT) nanomaterials summarized. Finally, this discusses challenges opportunities development ferroptosis-inducing agents, focusing discovering targets, improving selectivity, reducing toxic side effects. Keywords: inducers, molecules, PROTACs, PDT, SDT,

Language: Английский

Citations

9

From bench to bedside: targeting ferroptosis and mitochondrial damage in the treatment of diabetic cardiomyopathy DOI Creative Commons
Bin Liu, Qing Jin, Yi Sun

et al.

Frontiers in Endocrinology, Journal Year: 2025, Volume and Issue: 16

Published: April 25, 2025

Diabetic cardiomyopathy (DCM) is a common and fatal cardiac complication caused by diabetes, with its pathogenesis involving various forms of cell death mitochondrial dysfunction, particularly ferroptosis injury. Recent studies have indicated that damage play crucial roles in the onset progression DCM, though their precise regulatory mechanisms remain unclear. Of particular interest interaction between damage, as well synergistic effects, which are not fully understood. This review summarizes injury DCM explores molecular involved, an emphasis on interplay these two processes. Additionally, article offers overview targeted drugs shown to be effective cellular experiments, animal models, clinical trials, analyzing action potential side effects. The goal provide insights for future drug development applications. Moreover, challenges prospects multi-target combination therapies personalized medicine interventions practice offer strategic guidance comprehensive prevention management DCM.

Language: Английский

Citations

0

A tandem-unlocked cascade nanoreactor for high-contrast magnetic resonance imaging-guided enhanced ferroptosis-chemo synergistic therapy DOI Creative Commons
Weiping Liu, Alice H. Huang, Tianqi Luo

et al.

Materials Today Bio, Journal Year: 2025, Volume and Issue: unknown, P. 101852 - 101852

Published: May 1, 2025

Language: Английский

Citations

0

Design and synthesis of sulfonamide phenothiazine derivatives as novel ferroptosis inhibitors and their therapeutic effects in spinal cord injury DOI

Xinyue Bai,

Yanling Yang,

Yilin Luo

et al.

Bioorganic Chemistry, Journal Year: 2024, Volume and Issue: 148, P. 107458 - 107458

Published: May 19, 2024

Language: Английский

Citations

2

Quantitatively analyzing the dissociation and release of disulfide-containing organic nanoparticles DOI
Wenhai Lin, Lei Yin, Xin Wang

et al.

Journal of Materials Chemistry B, Journal Year: 2024, Volume and Issue: 12(37), P. 9289 - 9295

Published: Jan. 1, 2024

The disintegration of nanoparticles and drug release are important imperative for nanoparticle formulations therapeutic agents. However, quantitatively monitoring the nanomedicines is a major challenge. In this work, boron-dipyrromethene (BDP) was applied as model to study disassembly release. BDP dimers with disulfide ester bonds were synthesized, their made. accurate analysis bond breaking in could not be realized by using confocal laser scanning microscopy. Hence, possible products after cleavage quantified liquid chromatography tandem mass spectrometry (LC-MS/MS). endocytosed into cancer cells, broken promote disassociation Then, near-infrared investigated live mice fluorescence imaging LC-MS/MS. low (<10%) maintained original dimer structure

Language: Английский

Citations

1

Multimodal synergistic ferroptosis cancer therapy DOI
Nem Singh, Dahee Kim, Sunhong Min

et al.

Coordination Chemistry Reviews, Journal Year: 2024, Volume and Issue: 522, P. 216236 - 216236

Published: Sept. 25, 2024

Language: Английский

Citations

0